22 hrs ago
Notable Movers- OCZ Technology Group Inc. (NASDAQ:OCZ), Metabolix,...
StockMarketIntel.com issues a special report on the following stocks: OCZ Technology Group Inc. , Metabolix, Inc. , Amarin Corporation plc , Delcath Systems, Inc. .
Fri Dec 06, 2013
Stocks to Watch - Vitamin Blue Inc (OTCBB:VTMB), Amarin Corporation...
PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more.
Active Runners- Globalstar, Inc.(OTCMKTS:GSAT), Amarin Corporation...
CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains.
Thu Dec 05, 2013
Will Amarin And Arena See Better Sales In 2014?
I think the influx of new biotech investors learned some interesting lessons about the launch and subsequent commercialization of drugs this year.
Mon Dec 02, 2013
NASDAQ Gainers Watch List: Hologic Inc. (NASDAQ:HOLX) and Amarin...
Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Hologic Inc. and Amarin Corporation plc .
Amarin Corporation PLC Announces Notification Of Patent Allowances...
Amarin Corporation PLC Announces Notification Of Patent Allowances For U.S. Applications 13/685,281, And 13/685,291 Related To Triglyceride Lowering With A Mixture Of Omega-3 Free Fatty Acid In Both The MARINE And ANCHOR Patient Populations BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 2, 2013 -- Amarin Corporation plc , a biopharmaceutical company ... (more)
Stock's Buzzers - Amarin Corporation Plc (ADR) (NASDAQ:AMRN), Array...
Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout.
Sun Dec 01, 2013
Any Hopes Left For Amarin Bulls?
On October 29, the FDA dashed Amarin's hopes for its fish-oil-based drug, Vascepa, for treating patients suffering with high triglyceride, or TG, levels .
Fri Nov 29, 2013
News Buzz - Camtek LTD.(NASDAQ:CAMT), Oxygen Biotherapeutics,...
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
Wed Nov 27, 2013
Customer Interaction Solutions
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Amarin Corporation plc
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of a class comprising all purchasers of the common, call options or sellers of put options of Amarin Corporation plc between July 9, 2009 and October 15, 2013, inclusive .
Fri Nov 22, 2013
Morning Buzzers - Ross Stores, Inc. (NASDAQ:ROST), Splunk Inc...
At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before.
ARIA, MU, AMRN and ARUN added to NASDAQ Active Stock Watch List at...
Ariad Pharmaceuticals Inc. is currently up from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
Amarin faces another setback on expanded use of its lead drug
Amarin Corp Plc said the U.S. Food and Drug Administration did not accept its appeal for the review of a regulatory decision to revoke an agreement related to the trial of its lead drug that lowers a type of blood fat.
Wed Nov 20, 2013
Stocks on the Move - Amarin Corporation Plc (ADR) (NASDAQ:AMRN),...
High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout.
TrendingWallStreet.com Puts Out High Volume Alerts on TSL, DECN,...
Whether it's a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Tue Nov 19, 2013
Amarin Co. plc Given Hold Rating at Canaccord Genuity
's stock had its "hold" rating reaffirmed by investment analysts at Canaccord Genuity in a note issued to investors on Tuesday, Analyst Ratings News reports.
Sun Nov 17, 2013
Amarin, Sarepta And Vanda: Teachable Moments In Biotech
The last two years or so have seen the entire biotech sector catch fire. The SPDR Biotech ETF is up over 45% in that time, after only appreciating 26% in the six years prior.
Fri Nov 15, 2013
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in...
A complaint has been filed on behalf of all persons who purchased Amarin common stock between July 9, 2009 and October 15, 2013 in the District of New Jersey.
Amarin: How Cost Cutting Affects Cash Burn And Profitability
Amarin has slashed expenses in an attempt to shorten the path to profitability without approval for Vascepa's ANCHOR indication, although Amarin also mentioned that they are still vigorously pursuing the ANCHOR indication.
Thu Nov 14, 2013
Salix price target raised to $106 from $84 at Piper Jaffray
Salix price target raised to $106 from $84 at Piper Jaffray Piper Jaffray raised its price target for Salix Pharmaceuticals to $106 citing the acquisition of Santarus and the company's strong base business.